產(chǎn)品詳情
簡單介紹：
Anti-AFAP抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-AFAP抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-AFAP
Cat. Number:
Anti-AFAP抗體KL-9790R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Actin filament associated Anti-AFAP抗體protein (AFAP-110) interacts directly with Actin filaments through its C-terminal Actin binding domain. AFAP-110 contains additional protein-binding domains as well, and serves as an adaptor protein. AFAP-110 links signaling molecules to Actin filaments, provides a platform for the preparation of larger signaling complexes, activates Src kinases in response to cellular signals and also directly affects Actin organization as an Actin filament cross-linking protein. Deletion of certain binding elements of AFAP-110 results in altered Actin phenotypes; for instance, deletion of the leucine zipper motif causes repositioning of Actin into rosettes. Because inhibition of certain Actin cytoskeletal conformations inhibits cell division and movement, these conformational changes to AFAP-110, and thus Actin organization in the cell, represent a possible therapeutic target for controlling tumorigenesis and metastasis.
Also known as:
110 kDa actin filament Anti-AFAP抗體associated protein; 110 kDa actin filament-associated protein; Actin filament associated protein 1; Actin filament associated protein 110 kDa; Actin filament-associated protein 1; AFAP 1; AFAP 110; AFAP; AFAP-110; Afap1; AFAP1_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Cow, Horse, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human AFAP.
●
Predicted MolecularAnti-AFAP抗體 Weight: 81kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
Not yet tested in other applications.
Optimal working Anti-AFAP抗體dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working Anti-AFAP抗體dilutions must be determined by the end user.
kl008Ca01 血管生成素1(ANGPT1)多克隆抗體 Polyclonal Antibody to Angiopoietin 1 (ANGPT1)
kl008Ga01 血管生成素1(ANGPT1)多克隆抗體 Polyclonal Antibody to Angiopoietin 1 (ANGPT1)
kl008Hu01 血管生成素1(ANGPT1)多克隆抗體 Polyclonal Antibody to Angiopoietin 1 (ANGPT1)
kl008Mu01 血管生成素1(ANGPT1)多克隆抗體 Polyclonal Antibody to Angiopoietin 1 (ANGPT1)
kl008Po01 血管生成素1(ANGPT1)多克隆抗體 Polyclonal Antibody to Angiopoietin 1 (ANGPT1)
kl008Ra01 血管生成素1(ANGPT1)多克隆抗體 Polyclonal Antibody to Angiopoietin 1 (ANGPT1)
kl009Ga01 血管生成素2(ANGPT2)多克隆抗體 Polyclonal Antibody to Angiopoietin 2 (ANGPT2)
kl009Gu01 血管生成素2(ANGPT2)多克隆抗體 Polyclonal Antibody to Angiopoietin 2 (ANGPT2)
kl009Hu01 血管生成素2(ANGPT2)多克隆抗體 Polyclonal Antibody to Angiopoietin 2 (ANGPT2)
kl009Mu01 血管生成素2(ANGPT2)多克隆抗體 Polyclonal Antibody to Angiopoietin 2 (ANGPT2)
kl009Po01 血管生成素2(ANGPT2)多克隆抗體 Polyclonal Antibody to Angiopoietin 2 (ANGPT2)
kl009Ra01 血管生成素2(ANGPT2)多克隆抗體 Polyclonal Antibody to Angiopoietin 2 (ANGPT2)
kl009Rb51 血管生成素2(ANGPT2)多克隆抗體 Polyclonal Antibody to Angiopoietin 2 (ANGPT2)
kl010Bo01 結(jié)締組織生長因子(CTGF)多克隆抗體 Polyclonal Antibody to Connective Tissue Growth Factor (CTGF)
kl010Cp01 結(jié)締組織生長因子(CTGF)多克隆抗體 Polyclonal Antibody to Connective Tissue Growth Factor (CTGF)
kl010Ga01 結(jié)締組織生長因子(CTGF)多克隆抗體 Polyclonal Antibody to Connective Tissue Growth Factor (CTGF)
kl010Hu01 結(jié)締組織生長因子(CTGF)多克隆抗體 Polyclonal Antibody to Connective Tissue Growth Factor (CTGF)
kl010Mu01 結(jié)締組織生長因子(CTGF)多克隆抗體 Polyclonal Antibody to Connective Tissue Growth Factor (CTGF)
kl010Po01 結(jié)締組織生長因子(CTGF)多克隆抗體 Polyclonal Antibody to Connective Tissue Growth Factor (CTGF)
kl010Ra01 結(jié)締組織生長因子(CTGF)多克隆抗體 Polyclonal Antibody to Connective Tissue Growth Factor (CTGF)
